Business news – Page 49
-
BusinessUkraine plans to privatise state chemical producers
Government aims to develop struggling industry by attracting foreign investment
-
OpinionWhat's holding back continuous manufacturing?
Despite manay advantages, the move to flow chemistry in fine and speciality chemicals is slow
-
-
BusinessGM corn growers win US lawsuit against Syngenta
Kansas jury awards over $217m damages to farmers in the first of eight trials
-
NewsCancer committee under siege over glyphosate
US chemical industry group and Monsanto accuse agency of withholding information showing no link between glyphosate and cancer
-
NewsSpain loses 12,000 researchers in five years
Falling R&D investment is leading to a ‘brain drain’
-
ResearchLilly pushes continuous drug production limits
Integrated flow synthesis and purification process for prexasertib meets high industry standards
-
BusinessFDA asks Endo to take pain drug off market
Request part of larger strategy to address opioid misuse in the US
-
ArticleSygnature Discovery
Sygnature Discovery is part of an innovative partnership to bolster the life science sector in Nottingham
-
WebinarBusiness across borders
View our panel discussion, looking at the challenges of operating a chemistry business with an international perspective
-
BusinessJ&J licenses Protagonist’s inflammatory bowel peptide
Potential first-in-class treatment is just about to enter clinical trials
-
BusinessExplosion kills 10 at Chinese petrochemical plant
Nine others injured when gas tanker exploded in loading area
-
BusinessIneos expands North Sea oil and gas operations
Purchase of Danish Dong Energy and BP’s Forties pipeline will feed Grangemouth refinery
-
OpinionUnpicking a clinical trial death
A new study shows up off-target effects of a drug that proved deadly, and highlights the pitfalls of drug discovery
-
FeatureAccess to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
-
BusinessUS supreme court limits patent rights
Biotech industry is concerned that ruling will hit small companies
-
BusinessDow will face dioxin suit
US appeals court rules property owners have a valid case over soil contamination
-
BusinessFirst biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
BusinessWillow promises new medicines
Investigating tree’s metabolites throws up much more than aspirin
-
OpinionDrug pricing must be more transparent
Pricing is a complex issue - how can we make it clearer?